Resveratrol reverses doxorubicin-resistance and alleviates doxorubicin-induced myocardial injury in hepatocellular carcinoma.

Diao S, Diao S, Wu M, Su N, Quan Y

Open source

DOI
10.3389/fcell.2026.1925030
Published
2026
Container
Frontiers in cell and developmental biology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fcell.2026.1925030,
  title = {Resveratrol reverses doxorubicin-resistance and alleviates doxorubicin-induced myocardial injury in hepatocellular carcinoma.},
  author = {Diao S and Diao S and Wu M and Su N and Quan Y},
  year = {2026},
  journal = {Frontiers in cell and developmental biology},
  doi = {10.3389/fcell.2026.1925030},
  url = {https://doi.org/10.3389/fcell.2026.1925030}
}

RIS

TY  - JOUR
TI  - Resveratrol reverses doxorubicin-resistance and alleviates doxorubicin-induced myocardial injury in hepatocellular carcinoma.
AU  - Diao S
AU  - Diao S
AU  - Wu M
AU  - Su N
AU  - Quan Y
PY  - 2026
JO  - Frontiers in cell and developmental biology
DO  - 10.3389/fcell.2026.1925030
UR  - https://doi.org/10.3389/fcell.2026.1925030
ER  - 

APA

S, D., S, D., M, W., N, S., & Y, Q. (2026). Resveratrol reverses doxorubicin-resistance and alleviates doxorubicin-induced myocardial injury in hepatocellular carcinoma.. Frontiers in cell and developmental biology. https://doi.org/10.3389/fcell.2026.1925030

Source records